Author Information
Gary John Macfarlane is a renowned epidemiologist affiliated with the Epidemiology Group at the University of Aberdeen in Aberdeen, Scotland, UK. His extensive research primarily focuses on rheumatic and musculoskeletal diseases, with specific attention to conditions such as systemic lupus erythematosus, antiphospholipid syndrome, and axial spondyloarthritis. His work has made significant contributions to understanding and managing these conditions, especially in the context of cardiovascular risk and pain management.Research Contributions
Gary John Macfarlane has authored numerous influential papers, particularly in the field of rheumatology. In 2022 alone, his research touched on diverse aspects of musculoskeletal conditions, including cardiovascular risk management, health utility scores, work participation during COVID-19, and the impact of severe pain in patients with axial spondyloarthritis. His work often involves large-scale registry data and mixed-method studies, contributing to evidence-based practices for better patient outcomes. Notably, he has been involved in developing recommendations and protocols that have influenced clinical guidelines and patient care strategies globally.Aliases
Gary John Macfarlane is known by several aliases in academic and research circles, including G. J. Macfarlane, Gary J. Macfarlane, and G. Macfarlane, among others. These variations of his name appear across his numerous publications and citations.Publication and Citation Metrics
Citation Count |
26,389 |
H-index |
91 |
Paper Count |
553 |